Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Martha Jean Falkenstein, Ph.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. K23MH126193 (FALKENSTEIN, MARTHA J) Sep 13, 2021 - Aug 31, 2026
    Interpretation Bias as a Mechanism of Treatment Response in OCD
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kuckertz JM, McNally RJ, Riemann BC, Van Borkulo C, Bellet BW, Krompinger JW, Van Kirk N, Falkenstein MJ. Does the network structure of obsessive-compulsive symptoms at treatment admission identify patients at risk for non-response? Behav Res Ther. 2022 09; 156:104151. PMID: 35728274.
    Citations:    Fields:    
  2. Falkenstein MJ, Kelley KN, Dattolico D, Kuckertz JM, Bezahler A, Krompinger J, Webb CA, Beard C. Feasibility and Acceptability of Cognitive Bias Modification for Interpretation as an Adjunctive Treatment for OCD and Related Disorders: A Pilot Randomized Controlled Trial. Behav Ther. 2022 03; 53(2):294-309. PMID: 35227405.
    Citations:    Fields:    Translation:Humans
  3. Kuckertz JM, Rhee DW, Schreck M, Van Kirk N, Dattolico D, Falkenstein MJ. Reevaluating the psychometric properties of symptom measures within longitudinal contexts: The Yale-Brown Obsessive Compulsive Scale and Dimensional Obsessive-Compulsive Scale. Psychol Assess. 2021 Aug; 33(8):756-765. PMID: 33829846.
    Citations:    Fields:    Translation:Humans
  4. Snorrason I, Conway CC, Falkenstein MJ, Kelley KN, Kuckertz JM. Higher order compulsivity versus grooming dimensions as treatment targets for the DSM-5 obsessive-compulsive and related disorders. Depress Anxiety. 2022 01; 39(1):49-55. PMID: 33793029.
    Citations: 1     Fields:    Translation:HumansAnimals
  5. Kuckertz JM, Van Kirk N, Alperovitz D, Nota JA, Falkenstein MJ, Schreck M, Krompinger JW. Ahead of the Curve: Responses From Patients in Treatment for Obsessive-Compulsive Disorder to Coronavirus Disease 2019. Front Psychol. 2020; 11:572153. PMID: 33192865; PMCID: PMC7652992.
    Citations: 8     
  6. Brakoulias V, Starcevic V, Albert U, Arumugham SS, Bailey BE, Belloch A, Borda T, Dell'Osso L, Elias JA, Falkenstein MJ, Ferrao YA, Fontenelle LF, Jelinek L, Kay B, Lochner C, Maina G, Marazziti D, Matsunaga H, Miguel EC, Morgado P, Pasquini M, Perez-Rivera R, Potluri S, Reddy JYC, Riemann BC, do Rosario MC, Shavitt RG, Stein DJ, Viswasam K, Fineberg NA. The rates of co-occurring behavioural addictions in treatment-seeking individuals with obsessive-compulsive disorder: a preliminary report. Int J Psychiatry Clin Pract. 2020 Jun; 24(2):173-175. PMID: 31916881.
    Citations:    Fields:    Translation:Humans
  7. Brakoulias V, Starcevic V, Albert U, Arumugham SS, Bailey BE, Belloch A, Borda T, Dell'Osso L, Elias JA, Falkenstein MJ, Ferrao YA, Fontenelle LF, Jelinek L, Kalogeraki L, Kay B, Laurito LD, Lochner C, Maina G, Marazziti D, Martin A, Matsunaga H, Miguel EC, Morgado P, Mourikis I, Pasquini M, Perez Rivera R, Potluri S, Reddy JYC, Riemann BC, do Rosario MC, Shavitt RG, Stein DJ, Viswasam K, Wang Z, Fineberg NA. Treatments used for obsessive-compulsive disorder-An international perspective. Hum Psychopharmacol. 2019 01; 34(1):e2686. PMID: 30628745.
    Citations: 4     Fields:    Translation:Humans
  8. Falkenstein MJ, Nota JA, Krompinger JW, Schreck M, Garner LE, Potluri S, Van Kirk N, Ponzini G, Tifft E, Brennan BP, Mathes B, Cattie J, Crosby JM, Elias JA. Empirically-derived response trajectories of intensive residential treatment in obsessive-compulsive disorder: A growth mixture modeling approach. J Affect Disord. 2019 02 15; 245:827-833. PMID: 30699866.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  9. Falkenstein MJ, Conelea CA, Garner LE, Haaga DAF. Sensory over-responsivity in trichotillomania (hair-pulling disorder). Psychiatry Res. 2018 02; 260:207-218. PMID: 29202385.
    Citations: 1     Fields:    Translation:Humans
  10. Garner LE, Van Kirk N, Tifft ED, Krompinger JW, Mathes BM, Fraire M, Falkenstein MJ, Brennan BP, Crosby JM, Elias JA. Validation of the distress tolerance scale-short form in obsessive compulsive disorder. J Clin Psychol. 2018 06; 74(6):916-925. PMID: 29139125.
    Citations: 2     Fields:    Translation:Humans
  11. Falkenstein MJ, Mouton-Odum S, Mansueto CS, Golomb RG, Haaga DA. Comprehensive Behavioral Treatment of Trichotillomania: A Treatment Development Study. Behav Modif. 2016 May; 40(3):414-38. PMID: 26643276.
    Citations: 5     Fields:    Translation:Humans
  12. Falkenstein MJ, Haaga DA. Symptom accommodation, trichotillomania-by-proxy, and interpersonal functioning in trichotillomania (hair-pulling disorder). Compr Psychiatry. 2016 Feb; 65:88-97. PMID: 26773995.
    Citations: 2     Fields:    Translation:Humans
  13. Falkenstein MJ, Rogers K, Malloy EJ, Haaga DA. Race/Ethnicity and Treatment Outcome in a Randomized Controlled Trial for Trichotillomania (Hair-Pulling Disorder). J Clin Psychol. 2015 Jul; 71(7):641-52. PMID: 25846982; PMCID: PMC7261148.
    Citations:    Fields:    Translation:Humans
  14. Falkenstein MJ, Rogers K, Malloy EJ, Haaga DA. Predictors of Relapse Following Treatment of Trichotillomania. J Obsessive Compuls Relat Disord. 2014 Oct 01; 3(4):345-353. PMID: 25405081; PMCID: PMC4231486.
    Citations: 4     
  15. Agam Y, Greenberg JL, Isom M, Falkenstein MJ, Jenike E, Wilhelm S, Manoach DS. Aberrant error processing in relation to symptom severity in obsessive-compulsive disorder: A multimodal neuroimaging study. Neuroimage Clin. 2014; 5:141-51. PMID: 25057466.
    Citations: 17     Fields:    Translation:Humans
  16. Nelson SO, Rogers K, Rusch N, McDonough L, Malloy EJ, Falkenstein MJ, Banis M, Haaga DA. Validating indicators of treatment response: application to trichotillomania. Psychol Assess. 2014 Sep; 26(3):857-64. PMID: 24708079.
    Citations: 3     Fields:    Translation:Humans
  17. Rogers K, Banis M, Falkenstein MJ, Malloy EJ, McDonough L, Nelson SO, Rusch N, Haaga DAF. Stepped care in the treatment of trichotillomania. J Consult Clin Psychol. 2014 Apr; 82(2):361-367. PMID: 24491078.
    Citations: 14     Fields:    Translation:Humans
  18. Milad MR, Furtak SC, Greenberg JL, Keshaviah A, Im JJ, Falkenstein MJ, Jenike M, Rauch SL, Wilhelm S. Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit. JAMA Psychiatry. 2013 Jun; 70(6):608-18; quiz 554. PMID: 23740049.
    Citations: 106     Fields:    Translation:Humans
  19. Greenberg JL, Falkenstein M, Reuman L, Fama J, Marques L, Wilhelm S. The phenomenology of self-reported body dysmorphic disorder by proxy. Body Image. 2013 Mar; 10(2):243-6. PMID: 23384683.
    Citations: 1     Fields:    Translation:Humans
  20. Keuthen NJ, Rothbaum BO, Fama J, Altenburger E, Falkenstein MJ, Sprich SE, Kearns M, Meunier S, Jenike MA, Welch SS. DBT-enhanced cognitive-behavioral treatment for trichotillomania: A randomized controlled trial. J Behav Addict. 2012 Sep; 1(3):106-14. PMID: 26165460.
    Citations: 19     Fields:    
  21. Keuthen NJ, Rothbaum BO, Falkenstein MJ, Meunier S, Timpano KR, Jenike MA, Welch SS. DBT-enhanced habit reversal treatment for trichotillomania: 3-and 6-month follow-up results. Depress Anxiety. 2011 Apr; 28(4):310-3. PMID: 21456040.
    Citations: 16     Fields:    Translation:Humans
  22. Keuthen NJ, Rothbaum BO, Welch SS, Taylor C, Falkenstein M, Heekin M, Jordan CA, Timpano K, Meunier S, Fama J, Jenike MA. Pilot trial of dialectical behavior therapy-enhanced habit reversal for trichotillomania. Depress Anxiety. 2010 Oct; 27(10):953-9. PMID: 20721929.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  23. Ruchsow M, Reuter K, Hermle L, Ebert D, Kiefer M, Falkenstein M. Executive control in obsessive-compulsive disorder: event-related potentials in a Go/Nogo task. J Neural Transm (Vienna). 2007; 114(12):1595-601. PMID: 17610122.
    Citations: 21     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Falkenstein's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (85)
Co-Authors (20)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.